tiprankstipranks
Advertisement
Advertisement

CGON Stock Latest News

Alec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track
RatingsAlec Stranahan Reiterates Buy on CG Oncology, Lifts Price Target to $87 as Commercialization Plans Stay on Track
4d ago
CGON
CG Oncology announces departure of president, COO Ambaw Bellete
PremiumThe Fly
CG Oncology announces departure of president, COO Ambaw Bellete
5d ago
CGON
Wolfe sees CG Oncology COO exit as operational, no impact to key programs
PremiumThe Fly
Wolfe sees CG Oncology COO exit as operational, no impact to key programs
5d ago
CGON
CG Oncology Reshapes Executive Team Amid Leadership Transition
PremiumCompany Announcements
CG Oncology Reshapes Executive Team Amid Leadership Transition
5d ago
8K
CGON
CG Oncology initiated with a Peer Perform at Wolfe Research
PremiumThe Fly
CG Oncology initiated with a Peer Perform at Wolfe Research
12d ago
CGON
Buy Rating Reiterated on Robust Cretostimogene Data and De-Risked Phase 2 Program; $100 Price Target Maintained
PremiumRatingsBuy Rating Reiterated on Robust Cretostimogene Data and De-Risked Phase 2 Program; $100 Price Target Maintained
13d ago
CGON
CG Oncology reports first results from CORE-008 Cohort CX
Premium
The Fly
CG Oncology reports first results from CORE-008 Cohort CX
16d ago
CGON
CG Oncology price target raised to $82 from $77 at Truist
Premium
The Fly
CG Oncology price target raised to $82 from $77 at Truist
17d ago
CGON
CG Oncology price target raised to $81 from $79 at RBC Capital
PremiumThe Fly
CG Oncology price target raised to $81 from $79 at RBC Capital
19d ago
CGON
CG Oncology price target raised to $80 from $77 at Wedbush
PremiumThe Fly
CG Oncology price target raised to $80 from $77 at Wedbush
20d ago
CGON
CG Oncology price target raised to $96 from $91 at JPMorgan
PremiumThe Fly
CG Oncology price target raised to $96 from $91 at JPMorgan
20d ago
CGON
CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto
PremiumRatings
CG Oncology Earns Buy Rating as Analyst Sees High Phase III Success Odds and Strengthened BLA Timeline for Lead Asset Creto
20d ago
CGON
CG Oncology price target lowered to $83 from $84 at BofA
PremiumThe FlyCG Oncology price target lowered to $83 from $84 at BofA
21d ago
CGON
Analyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts
Premium
Ratings
Analyst Reiterates Buy on CG Oncology, Maintains $90 Price Target Ahead of Key Cretostimogene Data Readouts
21d ago
CGON
Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst
Premium
Ratings
Alec Stranahan Reiterates Buy on CG Oncology, Maintains $83 Price Target on Cretostimogene’s Best-in-Class Potential and Upcoming PIVOT-006 Catalyst
21d ago
CGON
CG Oncology reports Q1 EPS (71c), consensus (54c)
PremiumThe Fly
CG Oncology reports Q1 EPS (71c), consensus (54c)
23d ago
CGON
CG Oncology price target raised to $79 from $73 at RBC Capital
PremiumThe Fly
CG Oncology price target raised to $79 from $73 at RBC Capital
1M ago
CGON
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
CGON
SMMT
JPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
PremiumThe Fly
JPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
1M ago
JNJ
CGON
CG Oncology price target raised to $84 from $72 at BofA
PremiumThe FlyCG Oncology price target raised to $84 from $72 at BofA
2M ago
CGON
CG Oncology Appoints Veteran Jim DeTore as Chief Financial Officer
Premium
Company Announcements
CG Oncology Appoints Veteran Jim DeTore as Chief Financial Officer
2M ago
8K
CGON
JPMorgan healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
2M ago
CGON
TARA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >